Emerald Health Therapeutics (EMH) Stock Price, News & Analysis

Company Overview

Emerald Health Therapeutics, Inc., together with its subsidiaries, produces and sells medical cannabis for medical purpose in Canada. The company is also involved in developing natural health products. It offers dried cannabis strains, pre-rolls, and cannabis oil products to its medical patients. The company was formerly known as T-Bird Pharma Inc. and changed its name to Emerald Health Therapeutics, Inc. in June 2015. Emerald Health Therapeutics, Inc. is headquartered in Vancouver, Canada.

Key Stats

• Today's Range: C$0.25 to C$0.27
• 50-Day Range: C$0.26 to C$0.26
• 52-Week Range: C$0.15 to C$0.53
• Volume: 384,329 shs
• Average Volume: 644,760 shs
• Market Capitalization: C$52.28 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Industry, Sector and Symbol

• Stock Exchange: CVE
• Sector: Healthcare
• Industry: Biotechnology
• Sub-Industry: Biotechnology
• Current Symbol: CVE:EMH
• CIK: N/A
• Web: www.emerald.care
• Phone: +1-250-8189838
• Fax: N/A
• Employees: 161
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: 35.45
• Current Ratio: 2.97
• Quick Ratio: 2.61

Sales & Book Value

• Annual Sales: C$13.02 million
• Price / Sales: 4.02
• Cash Flow: C$0.33 per share
• Price / Cash Flow: 0.78
• Book Value: C$0.40 per share
• Price / Book: 0.64

Miscellaneous

• Outstanding Shares: 205,028,000
• Free Float: N/A
• Market Cap: C$52.28 million
• Optionable: Not Optionable
• Beta: N/A